NPT
RXRX icon

National Philanthropic Trust’s Recursion Pharmaceuticals RXRX Stock Holding History

National Philanthropic Trust’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,000
Closed -$165K – 288
2024
Q3 		$165K Hold
25,000
– – ﹤0.01% 243
2024
Q2 		$188K Hold
25,000
– – ﹤0.01% 242
2024
Q1 		$249K Sell
25,000
-261
-1% -$2.91K 0.01% 235
2023
Q4 		$249K Buy
+25,261
New +$180K 0.01% 266

Other funds holding RXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

National Philanthropic Trust's RXRX Position: Q4 2024 in Review

National Philanthropic Trust sold out of Recursion Pharmaceuticals (RXRX) in Q4 2024, closing a stake of 25,000 shares — an estimated $165K sold.

National Philanthropic Trust first reported a position in RXRX in Q4 2023 and held it in 4 quarters. The position peaked at $249K in Q1 2024. 316 funds tracked by Wall St. Rank hold RXRX as of Q4 2024.

  • National Philanthropic Trust reported no remaining Recursion Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • National Philanthropic Trust sold 25,000 Recursion Pharmaceuticals shares in Q4 2024, an estimated $165K.
  • National Philanthropic Trust first reported a position in Recursion Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • National Philanthropic Trust's Recursion Pharmaceuticals position peaked at $249K in Q1 2024.
  • 316 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q4 2024.

Based on National Philanthropic Trust's 13F filing for Q4 2024, filed 15 May 2026.